Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients

scientific article published in January 2003

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1053/META.2003.50003
P698PubMed publication ID12524658

P2093author name stringSacchetti C
Trucco M
Cavallo-Perin P
Cerutti F
Zanone MM
Rabbone I
Catalfamo E
Pietropaolo SL
P433issue1
P921main subjectautoantibodyQ785022
P1104number of pages5
P304page(s)25-29
P577publication date2003-01-01
P1433published inMetabolismQ15764354
P1476titleGlutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients
P478volume52

Reverse relations

cites work (P2860)
Q40451335An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control.
Q24682990Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
Q36681606ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
Q37599643HLA-associated phenotypes in youth with autoimmune diabetes
Q57831167Implicações clínicas da persistência de anti-GAD positivo e peptídeo C detectável em pacientes com diabetes melito tipo 1 de longa duração
Q34718501Interaction of onset and duration of diabetes on the percent of GAD and IA-2 antibody-positive subjects in the type 1 diabetes genetics consortium database